Biomarker testing of lung cancer in North America versus globally.
Smeltzer M, King J, Connolly C, Brunson K, Chau M, Chen S, Kerpel-Fronius A, Lantuejoul S, Mohan A, Plaxco A, Rice J, Basu Roy U, Santos R, Woodard G, Wynes M, Young A, Yatabe Y, Soo R, Kelly K. Biomarker testing of lung cancer in North America versus globally. Journal Of Clinical Oncology 2025, 43: 8541-8541. DOI: 10.1200/jco.2025.43.16_suppl.8541.Peer-Reviewed Original ResearchInternational Association for the Study of Lung CancerHigher incomeKey barriersBiomarker testingLung cancerPatient outcomesTesting practicesIdentified key barriersMiddle income countriesImpact patient outcomesBiomarker testing practicesStudy of Lung CancerSuboptimal due to lackChi-square testEarly-stage patientsEarly-stage LCFocus groupsAdvocacy partnersMedical educationLMICsIncome countriesMulti-disciplinary committeeSignificant disparitiesTurnaround timeMeasure improvement
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply